MJA
MJA InSight
MJA Careers
Viewpoint

The medical emergency team, evidence-based medicine and ethics

Ross K Kerridge and W Peter Saul
Med J Aust 2003; 179 (6): 313-315.

The medical emergency team (MET), which may be summoned by anyone in a hospital to treat a patient who appears acutely unwell, has been generally accepted as scientifically rational, with no adverse clinical outcomes and only modest resource requirements. Despite this, many centres appear to be awaiting “gold standard” evidence of its effectiveness. We suggest that the quest for evidence is providing scientific justification for institutional inertia, and that further delay in implementing this system may even be unethical.

Ross K Kerridge, MB BS, FRCA, FANZCA, Senior Specialist
W Peter Saul, MRCP, FRCA, FFICANZCA, Senior Specialist
Division of Anaesthesia, Intensive Care and Pain Management, John Hunter Hospital, Newcastle, NSW.
Article References: 
Reference Text: 
Lee A, Bishop G, Hillman K, Daffum K. The Medical Emergency Team. Anaesth Intensive Care 1995; 23: 183-186.
Reference Order: 
1
PubMed ID: 
7793590
Reference Text: 
McQuillan P, Pilkington S, Allan A, et al. Confidential inquiry into quality of care before admission to intensive care. BMJ 1998; 316: 1853-1858.
Reference Order: 
2
PubMed ID: 
9632403
Reference Text: 
Smith GB, Nolan J. Medical emergency teams and cardiac arrests in hospital. BMJ 2002; 324: 1215.
Reference Order: 
3
PubMed ID: 
12016195
Reference Text: 
O'Dea J, Pepperman M, Bion J. Comprehensive Critical Care: a national strategic framework in all but name. Intensive Care Med 2003; 29: 341.
Reference Order: 
4
PubMed ID: 
12594604
Reference Text: 
Bellomo R, Goldsmith D, Uchino S, et al. A prospective before-and-after trial of a medical emergency team. Med J Aust 2003; 179: 283-287.
Reference Order: 
5
PubMed ID: 
Reference Text: 
Deane SA, Gaudry PL, Pearson I, et al. Implementation of a trauma team. Aust N Z J Surg 1989; 59: 373-378.
Reference Order: 
6
PubMed ID: 
2730454
Reference Text: 
Buist M, Moore GE, Bernard SA, et al. Effects of a medical emergency team on reduction of incidence of and mortality from unexpected cardiac arrests in hospital: preliminary study. BMJ 2002; 324: 387-390.
Reference Order: 
7
PubMed ID: 
11850367
Reference Text: 
Petticrew M. Why certain systematic reviews reach uncertain conclusions. BMJ 2003; 326: 756-758.
Reference Order: 
8
PubMed ID: 
12676848
Reference Text: 
Sackett DL, Rosenberg WMC, Gray JAM, et al. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312: 71-72.
Reference Order: 
9
PubMed ID: 
8555924
Reference Text: 
Worrall J. What evidence in evidence-based medicine? Philos Sci 2002; 69: 316-331.
Reference Order: 
10
PubMed ID: 
Reference Text: 
Bandolier. Evidence based thinking about health care. How systematic reviews can disappoint. Available at: www.jr2.ox.ac.uk/bandolier/band93/b93-6.html (accessed May 2003).
Reference Order: 
11
PubMed ID: 
Reference Text: 
Rapid responses to: Buist M et al. BMJ 2002; 324: 387-390. Available at: bmj.com/cgi/eletters/324/7334/387 (accessed Jul 2003).
Reference Order: 
12
PubMed ID: 
Reference Text: 
Ellis J, Mulligan I, Rowe J, Sackett DL. Inpatient general medicine is evidence-based. Lancet 1995; 346: 407-410.
Reference Order: 
13
PubMed ID: 
7623571
Reference Text: 
Kerridge I, Lowe M, Henry D. Ethics and evidence based medicine. BMJ 1998; 316: 1151-1153.
Reference Order: 
14
PubMed ID: 
9552959
Reference Text: 
Leeder SR, Rychetnik L. Ethics and evidence-based medicine. Med J Aust 2001; 175: 161-164.
Reference Order: 
15
PubMed ID: 
11548084
Reference Text: 
Little M. “Better than numbers . . .” A gentle critique of evidence-based medicine. Aust N Z J Surg 2003; 73: 177-182.
Reference Order: 
16
PubMed ID: 
Reference Text: 
Wooldridge M, quoted by Downey M. “Trust me I'm a doctor”. Sydney Morning Herald 1997; 10 May: 1.
Reference Order: 
17
PubMed ID: 
Reference Text: 
Manns BJ, Lee H, Doig CJ, et al. An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med 2002; 347: 993-1000.
Reference Order: 
18
PubMed ID: 
12324556
Reference Text: 
Chalfin DB, Teres D, Rapoport J. A price for cost-effectiveness: implications for recombinant human activated protein C (rhAPC). Crit Care Med 2003; 31: 306-308.
Reference Order: 
19
PubMed ID: 
12545034
Reference Text: 
Eichacker PQ, Natanson C. Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials. Crit Care Med 2003; 31 (1 Suppl): S94-S96.
Reference Order: 
20
PubMed ID: 
12544982
Reference Text: 
Spiegel BM, Targownik L, Dulai GS, Gralnek IM. The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis. Ann Intern Med 2003; 138: 795-806.
Reference Order: 
21
PubMed ID: 
12755551
Reference Text: 
Marra CA, Esdaile JM, Sun H, Anis AH. The cost of COX inhibitors: how selective should we be? J Rheumatol 2000; 27: 2731-2733.
Reference Order: 
22
PubMed ID: 
11128654

The full contents of this page are only available to subscribers.